Sponsored Links
| Perceptive Informatics® Takes Lead In Practical Application Of Response Criteria For Lymphoma And Leukemia In Clinical Trials |
 |
 |
 |
| Medical News - Clinical Trials and Drug Trials | |||
|
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), announced that it is taking a lead role in the biopharmaceutical industry to advance the practical application of revised response criteria for Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) to clinical trials. Bruce D. Cheson, M.D... Read more: Clinical Trials / Drug Trials News From Medical News Today
|